Summary
Machine-generated summaryThis public tender covers recurring supplies of medicinal products containing the active substance natalizumab, an immunosuppressant. The buyer is not named in the announcement, and the place of delivery, estimated contract value and submission deadline are not specified. Products must meet the requirements of SÚKL, the Czech State Institute for Drug Control. The procurement is a public tender conducted in the Czech language. Suppliers of pharmaceuticals able to deliver natalizumab medicines on a repeating basis and comply with the SÚKL requirements may participate. Exact conditions are defined in the tender documents.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile44 open tenders right now
- Medical needles - Echogenic needle 1 day left
- Vascular prostheses - Linear ePTFE vascular prosthesis 1 day left
- Czech Republic - Antineoplastic and immunomodulating agents - INTERFERON BETA-1A 2026 2 days left
Recent awards
Similar tenders
1
day left
€548,450
est. value
1
day left
€1,436,973
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €9,890,377
- Buyer track record on Aperlena
- 761 notices tracked · 400 awarded
- €531,888,821 in awarded contracts
Never miss a tender like this
149 new notices in Medical equipment & pharmaceuticals in Czechia in the last 7 days. Get an email when new ones appear. Free.
Set up my alert